Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.20101109